Header Logo

Connection

Dongfeng Qu to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications Dongfeng Qu has written about Drug Resistance, Neoplasm.
Dongfeng Qu
Connection Strength
0.139
Drug Resistance, Neoplasm
  1. Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer. Int J Cancer. 2018 09 01; 143(5):1162-1175.
    View in: PubMed
    Score: 0.139
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.